Metropolitan Life Insurance Company (MetLife)’s Affimed AFMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-864	Closed	-$10.7K	–	2311
2022 Q4	$10.7K	Hold	864	–	–	﹤0.01%	2263
2022 Q3	$17.8K	Buy	864 +471	+120%	+$13.1K	﹤0.01%	2082
2022 Q2	$10.9K	Sell	393 -389	-50%	-$13.3K	﹤0.01%	2298
2022 Q1	$34.2K	Sell	782 -2,352	-75%	-$102K	﹤0.01%	1809
2021 Q4	$173K	Buy	3,134 +194	+7%	+$12K	﹤0.01%	2123
2021 Q3	$182K	Buy	+2,940	New	+$194K	﹤0.01%	2156
2021 Q2	–	Sell	-3,090	Closed	-$244K	–	2712
2021 Q1	$244K	Buy	3,090 +692	+29%	+$44.9K	﹤0.01%	1876
2020 Q4	$140K	Buy	2,398 +77	+3%	+$3.63K	﹤0.01%	2179
2020 Q3	$78.7K	Sell	2,321 -156	-6%	-$5.91K	﹤0.01%	2355
2020 Q2	$114K	Buy	+2,477	New	+$68.9K	﹤0.01%	2174
2019 Q4	–	Sell	-2,373	Closed	-$69.8K	–	2537
2019 Q3	$69.8K	Buy	+2,373	New	+$70.6K	﹤0.01%	2458

Other funds holding AFMD

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPSPJS

General Pension Society PZU Joint Stock Warsaw, Poland $668M AUM 50.44% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AFMD Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Affimed (AFMD) in Q1 2023, closing a stake of 864 shares — an estimated $10.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AFMD in Q3 2019 and held it in 11 quarters. The position peaked at $244K in Q1 2021. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 864 Affimed shares in Q1 2023, an estimated $10.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Affimed in Q3 2019 and held it in 11 quarters.
Metropolitan Life Insurance Company (MetLife)'s Affimed position peaked at $244K in Q1 2021.
94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.